CHAM
Clear Harbor Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.42M | Buy |
8,419
+1,616
| +24% | +$848K | 0.33% | 69 |
|
|
2025
Q1 | $4.31M | Buy |
6,803
+1,382
| +25% | +$877K | 0.34% | 69 |
|
|
2024
Q4 | $3.86M | Buy |
5,421
+3,006
| +124% | +$2.14M | 0.31% | 72 |
|
|
2024
Q3 | $2.54M | Buy |
2,415
+21
| +0.9% | +$22.1K | 0.21% | 93 |
|
|
2024
Q2 | $2.52M | Buy |
2,394
+6
| +0.3% | +$6.31K | 0.22% | 93 |
|
|
2024
Q1 | $2.3M | Buy |
2,388
+22
| +0.9% | +$21.2K | 0.2% | 97 |
|
|
2023
Q4 | $2.08M | Buy |
2,366
+115
| +5% | +$101K | 0.19% | 94 |
|
|
2023
Q3 | $1.85M | Sell |
2,251
-8
| -0.4% | -$6.58K | 0.19% | 101 |
|
|
2023
Q2 | $1.62M | Buy |
2,259
+11
| +0.5% | +$7.9K | 0.16% | 113 |
|
|
2023
Q1 | $1.85M | Buy |
2,248
+10
| +0.4% | +$8.22K | 0.19% | 108 |
|
|
2022
Q4 | $1.61M | Buy |
2,238
+62
| +3% | +$44.7K | 0.2% | 95 |
|
|
2022
Q3 | $1.5M | Sell |
2,176
-20
| -0.9% | -$13.8K | 0.21% | 92 |
|
|
2022
Q2 | $1.3M | Buy |
2,196
+8
| +0.4% | +$4.73K | 0.17% | 102 |
|
|
2022
Q1 | $1.53M | Buy |
2,188
+247
| +13% | +$172K | 0.17% | 107 |
|
|
2021
Q4 | $1.23M | Buy |
1,941
+14
| +0.7% | +$8.84K | 0.13% | 135 |
|
|
2021
Q3 | $1.17M | Buy |
1,927
+133
| +7% | +$80.5K | 0.02% | 140 |
|
|
2021
Q2 | $1M | Buy |
1,794
+268
| +18% | +$150K | 0.12% | 143 |
|
|
2021
Q1 | $722K | Buy |
+1,526
| New | +$722K | 0.09% | 166 |
|